Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Collecting Information From Patients Enrolled in the Breast Specialized Program of Research Excellence

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT01004562
First received: October 29, 2009
Last updated: October 11, 2015
Last verified: November 2012
  Purpose

RATIONALE: Collecting and storing information from patients with cancer to study in the future may help doctors learn more about cancer.

PURPOSE: This study is collecting information from patients enrolled in the Breast Specialized Program of Research Excellence.


Condition Intervention
Breast Cancer
Other: informational intervention

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: The Breast Cancer Specialized Program of Research Excellence (SPORE): Core A-Administrative/Biostatistics Core

Resource links provided by NLM:


Further study details as provided by University of Alabama at Birmingham:

Primary Outcome Measures:
  • Administrative and biostatistical support for the Breast Specialized Program of Research Excellence [ Time Frame: 5 years ] [ Designated as safety issue: No ]

Enrollment: 1025
Study Start Date: August 2007
Study Completion Date: August 2012
Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
Detailed Description:

OBJECTIVES:

  • Provide a database for administrative and biostatistical support for the Breast Specialized Program of Research Excellence.

OUTLINE: Data is collected from patients for future research studies.

PROJECTED ACCRUAL: A total of 535 patients will be accrued for this study.

  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Breast cancer patients of any age
Criteria

DISEASE CHARACTERISTICS:

  • Diagnosis of breast cancer

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • Not specified
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01004562

Locations
United States, Alabama
UAB Comprehensive Cancer Center
Birmingham, Alabama, United States, 35294
Sponsors and Collaborators
University of Alabama at Birmingham
National Cancer Institute (NCI)
Investigators
Principal Investigator: Yufeng Li, PhD University of Alabama at Birmingham
  More Information

Responsible Party: University of Alabama at Birmingham
ClinicalTrials.gov Identifier: NCT01004562     History of Changes
Other Study ID Numbers: CDR0000378061  UAB-X010112005 
Study First Received: October 29, 2009
Last Updated: October 11, 2015
Health Authority: United States: Institutional Review Board

Keywords provided by University of Alabama at Birmingham:
breast cancer

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on September 23, 2016